ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is characterized by the absent expression of estrogen (ER) and progesterone (PR) receptors and lack of human epidermal growth factor receptor 2 (HER-2) overexpression/amplification.